Emma & Jade are representing us at @lungcancereurope.bsky.social’s Conference in Vienna.
There’s a strong line up of speakers across 3 days. We’re looking forward to hearing the key takeaways they bring back, & how this can help our work for people affected by ALK+ #lungcancer in the UK. #LCSM
In this UK NHS #LungCancer trial, AI cut chest X-ray reporting time, but not time to CT, diagnosis or treatment. Faster reporting alone does not fix a slow lung cancer pathway. The hold-up comes in what happens after the X-ray. #LCSM
ascoai.org/articles/202...
We’re delighted to announce Dr Tom Newsom-Davis as keynote speaker at our 5th ALK+ UK National Conference. 💙
Join us in London 25–27 Sept for a weekend of expert talks, trusted information & time to connect with others in the ALK+ #LungCancer community #LCSM
www.alkpositive.org.uk/national-con...
New March 2026 data from Cancer Research UK shows #lungcancer death rates in the UK have fallen by 22% over the past decade.
But the picture is very different for men and women. Over the last decade, lung cancer incidence rates rose by 8% in women, while falling by 13% in men.
#LCSM
A 🆕 article in Lung Cancer adds more detail from the ALINA trial, showing that adjuvant alectinib continued to show disease-free survival benefit over chemo across surgical subgroups in resected early-stage ALK+ #LungCancer. ALINA isn’t new, but this gives a closer look at who benefited. #LCSM
Interesting to see Ben Solomon speak about early immune-based approaches in ALK+ lung cancer at #ELCC26.
Alongside TKIs, researchers are also looking at whether the immune system could be better engaged in ALK+ #lungcancer, including through ALK vaccines and ALK-specific T cell approaches. #LCSM
As China looks to commercial companies to drive innovation, it has a golden opportunity to support open science and increase its output in key areas
go.nature.com/4dIBvDY
A poignant read in this weekend’s Guardian. Janis Chen writes about living with stage 4 #lungcancer and the in-between space that can come with it - ongoing treatment, uncertainty, fatigue, scanxiety, and trying to keep living around all of that. #LCSM
www.theguardian.com/society/2026...
🌟 @alkpositiveuk.bsky.social is now PIF TICK re-certified.
This means its health information continues to be:
- Evidence-based
- Up-to-date
- Easy to use and understand
Want to get PIF TICK certified? Read this: lnkd.in/ek8kF_dS
#HealthInformation
#PIFTICK
This study suggests some ALK+ lung cancers may carry a weakness called MTAP loss that future treatment combinations could exploit. Though not something changing care now, it could be an important lead for what comes next. #LCSM #LungCancer
www.annalsofoncology.org/article/S092...
The image features Veena Raleigh, a Senior Fellow at The King's Fund. Text highlights a report by the ONS about deteriorating self-reported health among economically inactive or unemployed individuals, particularly in deprived areas.
Recent ONS data on the 'Changes in individual self-reported health between Census 2011 and Census 2021, in England' highlight that the self-reported health of people who are economically inactive or unemployed, and of those living in deprived areas, is deteriorating. https://bit.ly/4deSf5t
Booking is now open for the London Immunity in Health and Disease Symposium, taking place here at the Crick on 14-15 September.
Early bird tickets are available until 30 April.
www.eventbrite.co.uk/e/the-london...
‼️ 🏃♀️ We’ve got 3 spaces for the Brighton Marathon 12 Apr, but you’ll need to be super quick entry closes mid afternoon tomorrow (12 Mar).
🔹 We cover your entry
🔹 You commit to modest fundraising
🔹 You run for ALK+ UK & help raise awareness for #lungcancer
www.alkpositive.org.uk/get-involved...
Repeat chest infections can be an overlooked sign of #lungcancer.
Prof Robert Rintoul says slow clearing or repeat chest infections, should raise concern.
Finding lung cancer early is key to better outcomes, so awareness of less obvious symptoms is key. #LCSM
www.telegraph.co.uk/health-fitne...
photo of the 1970 march showing a crowd of women and the banner ‘women of the world unite’
Giving thanks for all amazing and inspiring women around the world on International Women’s Day
We will never give up fighting for equality, for what is just and fair, and for each other 💪
#WomenOfTheWorldUnite
#WomenInScience 🧪
International Women’s Day Highlights 2026: Honoring Women in Oncology
@erikahamilton9.bsky.social @elinardou.bsky.social @latinamd.bsky.social @lilliansiu.bsky.social
oncodaily.com/not-to-miss/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IWD2026
Lung cancer is rising in young, non-smoking women yet many face misdiagnosis & delays, because it isn’t expected in people their age.
This #InternationalWomensDay, let’s make #lungcancer in young, non-smoking women part of the conversation.
🙏 to our ALK+ UK commmunity for sharing their stories.
Call for Expressions of Interest for Clinical Oncology and Surgery Representation on the BTOG Steering Committee:
Learn more: https://www.btog.org/join-the-btog-steering-committee/
Deadline for submission of expression of interest is Monday 9th March 2026.
#LCSM #LungCancer
At @btog.bsky.social 2026 clinicians shared real world experience managing side effects from lorlatinib in ALK+ #lungcancer.
As people stay on targeted therapy for years, practical strategies like dose adjustment and careful monitoring are becoming central to long term care. #LCSM
🚀New NLCA blog: State of the Nation 2026: progress in earlier diagnosis and the challenge of rising demand
By Dr Lauren Dixon, NLCA Clinical Fellow
📌More people diagnosed earlier
📌Growing demand and pressure on services
Read the blog here👉 buff.ly/3qrBYu1
@btog.bsky.social @lcnuk.bsky.social
Day 2 at #BTOG26.
ALK Positive UK is in Edinburgh alongside EGFR+ UK & the Ruth Strauss Foundation.
A packed programme of #lungcancer science, trials & debate plus an important chance for charities to connect directly with the clinicians & researchers influencing care.
#LCSM
NEW PAPER: Our decision-modelling study showed specialist palliative care in England (home and hospital) saved £817M, freed 1.5M hospital bed days, helped 20,000+ people die outside hospital and improved quality of life. #palliativecare #palliativemedicine
At @btog.bsky.social 2026 we’re sharing an evaluation of the See Through the Symptoms #lungcancer awareness campaign.
It was developed by jointly by ALK+ UK, EGFR+ UK & the Ruth Strauss Foundation to encourage HCPs to consider lung cancer in people with persistent or unexplained symptoms. #LCSM
Burnout isn’t about individual resilience. It’s about the conditions we create.
Our latest blog shares four practical actions from clinical leaders on how to rebuild control, trust and wellbeing across health and care.
Read the blog and join the movement – https://bit.ly/40zYhpM
We’re excited to be working with @britsciassoc.bsky.social to co-lead EDIS, a coalition working to improve equality, diversity and inclusion in science and health research.
Find out more about the plans for EDIS's next chapter ⤵️ www.crick.ac.uk/news/2026-03...
Hear more about the proposals for a bold and ambitious new approach to UK pharmacy professional leadership and have your say. Join one of the webinars from The UK Pharmacy Professional Leadership Advisory Board.
www.eventbrite.com/cc/next-step...
We’ll be in Edinburgh this week for #BTOG26. Debra Montague, our Chair, will be there following the latest discussions in thoracic oncology.
For people living with ALK+ #lungcancer, the conversation around brain mets, resistance, treatment sequencing & access to next-line options is critical. #LCSM
ALK+ #lungcancer often means staying on a TKI for years. If radiotherapy is needed for brain metastases or a growing spot, the big question is whether to continue the drug.
New ESMO–ESTRO guidance says combining them can increase side effects. #LCSM
www.sciencedirect.com/science/arti...
3.5M people in the UK are living with a rare disease. ALK+ #lungcancer is one of them.
On #RareDiseaseDay, we stand with everyone living with ALK+ & with the wider rare disease community calling for earlier diagnosis, equitable access to testing & treatment, & consistent specialist care. #LCSM
1 in 10 adults in the UK have been affected by misinformation.
That rises to 2 in 10 for black and ethnic minority communities.
In our new video in partnership with
@england.nhs.uk, Dr Sylvia Kama-Kieghe talks about what you can do to find trusted health information.
youtube.com/shorts/A9b6O...
